DE602006015727D1 - Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 - Google Patents

Verfahren zur messung von plasmaspiegeln von pentraxin ptx3

Info

Publication number
DE602006015727D1
DE602006015727D1 DE602006015727T DE602006015727T DE602006015727D1 DE 602006015727 D1 DE602006015727 D1 DE 602006015727D1 DE 602006015727 T DE602006015727 T DE 602006015727T DE 602006015727 T DE602006015727 T DE 602006015727T DE 602006015727 D1 DE602006015727 D1 DE 602006015727D1
Authority
DE
Germany
Prior art keywords
ptx3
measuring plasma
pentraxin ptx3
plasma
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006015727T
Other languages
English (en)
Inventor
Alberto Mantovani
Giuseppe Peri
Fabio Pasqualini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Humanitas Mirasole SpA
Original Assignee
Humanitas Mirasole SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humanitas Mirasole SpA filed Critical Humanitas Mirasole SpA
Publication of DE602006015727D1 publication Critical patent/DE602006015727D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002—Partitioning blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Lasers (AREA)
DE602006015727T 2006-12-22 2006-12-22 Verfahren zur messung von plasmaspiegeln von pentraxin ptx3 Active DE602006015727D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2006/000872 WO2008078344A1 (en) 2006-12-22 2006-12-22 A method for measuring plasma levels of long pentraxin ptx3

Publications (1)

Publication Number Publication Date
DE602006015727D1 true DE602006015727D1 (de) 2010-09-02

Family

ID=38050157

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006015727T Active DE602006015727D1 (de) 2006-12-22 2006-12-22 Verfahren zur messung von plasmaspiegeln von pentraxin ptx3

Country Status (9)

Country Link
US (1) US20090317843A1 (de)
EP (1) EP2092342B1 (de)
JP (1) JP2010513917A (de)
CN (1) CN101606067A (de)
AT (1) ATE475098T1 (de)
AU (1) AU2006352299A1 (de)
CA (1) CA2671139A1 (de)
DE (1) DE602006015727D1 (de)
WO (1) WO2008078344A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5334742B2 (ja) * 2009-08-11 2013-11-06 関東化学株式会社 水溶性アンモニウムポリマーを含有する検体前処理試薬、および検体前処理方法
US20120034706A1 (en) * 2010-08-06 2012-02-09 Hakujyujikai Medical Inc. Method for assessing inflammatory condition
GB201309358D0 (en) 2013-05-24 2013-07-10 King S College London Aiding assessment of prognosis in inflammatory disease
MY160723A (en) * 2013-12-30 2017-03-15 Univ Putra Malaysia An anticoagulant
WO2019056991A1 (zh) * 2017-09-19 2019-03-28 臻崴生物科技有限公司 单克隆抗体或其抗原结合片段及其用途
CN110514844A (zh) * 2019-08-14 2019-11-29 湖南山河生物医学技术孵化中心(有限合伙) 一种人五聚素3磁微粒化学发光免疫定量检测试剂盒及其制备方法
CN111024956A (zh) * 2019-12-31 2020-04-17 江苏美克医学技术有限公司 一种检测ptx3的时间分辨荧光免疫层析试剂盒
EP4399521A1 (de) * 2021-09-10 2024-07-17 Quidel Corporation Agglutinierungsmittel, vorrichtungen und verfahren für vollbluttests

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1325043A (en) * 1969-08-04 1973-08-01 Greenspan D J Method of separating blood components
US5652148A (en) * 1993-04-20 1997-07-29 Actimed Laboratories, Inc. Method and apparatus for red blood cell separation
FR2774473B1 (fr) * 1998-02-05 2000-05-12 Pasteur Sanofi Diagnostics Procede de dosage des troponines dans des milieux biologiques permettant d'eviter les interferences dues a l'heparine
EP1320753A2 (de) * 2000-09-25 2003-06-25 Abbott Laboratories Verfahren und kits zur reduzierung von störungen in plasma oder serum enthaltenden proben bei spezifische bindungstests unter verwendung eines grossen polycations
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
EP1720014A4 (de) * 2004-02-25 2008-01-16 Perseus Proteomics Inc Verfahren zur beurteilung des ausmasses einer vaskulopathie
ITMI20040858A1 (it) * 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
US9081018B2 (en) * 2005-12-29 2015-07-14 Humanitas Mirasole S.P.A. Diagnostic test for inflammatory endothelial dysfunctions in pregnancies

Also Published As

Publication number Publication date
CN101606067A (zh) 2009-12-16
US20090317843A1 (en) 2009-12-24
CA2671139A1 (en) 2008-07-03
EP2092342B1 (de) 2010-07-21
AU2006352299A1 (en) 2008-07-03
EP2092342A1 (de) 2009-08-26
JP2010513917A (ja) 2010-04-30
ATE475098T1 (de) 2010-08-15
WO2008078344A1 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
DE602006015727D1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
DE112008000683A5 (de) Messeinrichtung und Verfahren zur optischen Konzentrationsbestimmung von Blutzucker und/oder Laktat in biologischen Systemen
WO2008021290A3 (en) Organ-specific proteins and methods of their use
EP2045597A4 (de) Verfahren zur messung des hämatokritwertes einer blutprobe, verfahren zur messung der analytkonzentration in einer blutprobe, sensorchip und sensoreneinheit
EP2058651A4 (de) Verfahren zur messung des hämatokritwertes einer blutprobe, verfahren zur messung der analytkonzentration in einer blutprobe, sensorchip und sensoreneinheit
DE602006018721D1 (de) Cyanidfreie lösungsmittelzusammensetzung und verwendungsverfahren dafür zur messung von hämoglobin und weissen blutkörperchen
BR112012013362A2 (pt) sistema para a determinação de um valor para pelo menos um parâmetro que descreve a atividade microbiana de organismos biológicos individuais em uma amostra de líquido, e, método para a determinação da atividade microbiana em uma amostra de líquido
WO2009090553A3 (en) Compositions and methods of detecting post-stop peptides
ATE525648T1 (de) Testelement mit nanofasern
EP2634573A3 (de) Kartuschenvorrichtung für ein Messsystem zur Messung der viskoelastischen Eigenschaften einer Probenflüssigkeit, zugehöriges Messsystem und zugehöriges Verfahren
EP2662453A3 (de) Nachweis und Behandlung von Schizophrenie
BRPI0812875B8 (pt) " método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste
EP2284526A4 (de) Biosensorsystem, sensorspitze und verfahren zur messung einer analytkonzentration in einer blutprobe
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
WO2009142744A3 (en) Predicting hemostatic risk; dependence on plasma composition
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
BRPI0916101A2 (pt) "método para determinar o estágio de uma gravidez, dispositivo adaptado para detectar os níveis/a quantidade de hpl ou de um fragmento do mesmo em uma amostra de fluido corpóreo derivado de uma fêmea humana, kit e uso de um anticorpo anti-hpl"
MX2020006728A (es) Metodos para medir analito y/o proteina en muestras biologicas.
DE602007007775D1 (de) Reagenz für hämoglobinabbau
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
EP2081029A3 (de) Biomarker zur Diagnose diabetischer Retinopathie
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis